<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BioScreening.net &#187; Genomics &amp; Pharmacogenomics</title>
	<atom:link href="http://www.bioscreening.net/category/news/genomics/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.bioscreening.net</link>
	<description>BioScreening news and events</description>
	<lastBuildDate>Thu, 29 Dec 2011 08:21:20 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
		<item>
		<title>Molecular Target for Screening:  G-Protein-Coupled Receptors</title>
		<link>http://www.bioscreening.net/2010/08/19/molecular-target-for-screening-g-protein-coupled-receptors/</link>
		<comments>http://www.bioscreening.net/2010/08/19/molecular-target-for-screening-g-protein-coupled-receptors/#comments</comments>
		<pubDate>Thu, 19 Aug 2010 19:10:41 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Libraries]]></category>
		<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Targeted Libraries]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/?p=1021</guid>
		<description><![CDATA[Newark, DE. August, 2010 – Press Release &#8211; TimTec, LLC. &#8211; Molecular Target for Screening:  G-Protein-Coupled Receptors, ActiTarg-G G-Protein-Coupled Receptors are the largest gene families in the human genome and, rightfully so, have become the leading molecular target in 2008. In 2009 SBS April meeting in Lille, France, followed-up with screening trends report stating that  [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2010/08/19/molecular-target-for-screening-g-protein-coupled-receptors/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bioâ€™s enterprise platform wins award at Bio-IT World Expo in Boston</title>
		<link>http://www.bioscreening.net/2009/05/10/clc-bio%e2%80%99s-enterprise-platform-wins-award-at-bio-it-world-expo-in-boston/</link>
		<comments>http://www.bioscreening.net/2009/05/10/clc-bio%e2%80%99s-enterprise-platform-wins-award-at-bio-it-world-expo-in-boston/#comments</comments>
		<pubDate>Mon, 11 May 2009 00:32:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Grants and Awards]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2009/05/10/clc-bio%e2%80%99s-enterprise-platform-wins-award-at-bio-it-world-expo-in-boston/</guid>
		<description><![CDATA[Boston, Massachusetts, USA &#8212; April 30, 2009 &#8212; CLC bioâ€™s enterprise platform for Next Generation Sequencing data analysis, CLC Genomics Server, has just been awarded the â€œBest of Showâ€ prize at the Bio-IT World Conference &#038; Expo 2009 &#8211; an award judged by a team of Bio-IT World magazine editors and leading industry experts. Bio-IT [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2009/05/10/clc-bio%e2%80%99s-enterprise-platform-wins-award-at-bio-it-world-expo-in-boston/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GEN Reports on the Trend Toward Predictive Toxicogenomics</title>
		<link>http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/</link>
		<comments>http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/#comments</comments>
		<pubDate>Thu, 20 Nov 2008 17:00:22 +0000</pubDate>
		<dc:creator>Editor</dc:creator>
				<category><![CDATA[Compound Screening]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[News by Region]]></category>
		<category><![CDATA[News by Subject]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/</guid>
		<description><![CDATA[NEW ROCHELLE, N.Y., Nov 19, 2008 /PRNewswire via COMTEX/ &#8212; Biotech scientists increasingly are applying genomics technologies to toxicology research to better understand the effects of novel drug candidates on a variety of organ systems, reports Genetic Engineering &#038; Biotechnology News (GEN). They are especially interested in figuring out a new compound&#8217;s mechanism of action [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/20/gen-reports-on-the-trend-toward-predictive-toxicogenomics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Applied Biosystems and Asuragen Collaborate with the Critical Path Institute to Improve Drug Toxicity Screening</title>
		<link>http://www.bioscreening.net/2008/11/11/applied-biosystems-and-asuragen-collaborate-with-the-critical-path-institute-to-improve-drug-toxicity-screening/</link>
		<comments>http://www.bioscreening.net/2008/11/11/applied-biosystems-and-asuragen-collaborate-with-the-critical-path-institute-to-improve-drug-toxicity-screening/#comments</comments>
		<pubDate>Tue, 11 Nov 2008 18:59:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/11/11/applied-biosystems-and-asuragen-collaborate-with-the-critical-path-institute-to-improve-drug-toxicity-screening/</guid>
		<description><![CDATA[FOSTER CITY, Calif., Nov 06, 2008 (BUSINESS WIRE) &#8212; Drug toxicity accounts for billions of lost dollars to the pharmaceutical industry each year and is a leading cause of pre-clinical drug failures. The U.S. Food and Drug Administration (FDA) and other regulatory organizations have called upon the pharmaceutical industry to develop more effective tools to [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/11/11/applied-biosystems-and-asuragen-collaborate-with-the-critical-path-institute-to-improve-drug-toxicity-screening/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The German Cancer Research Center Investigates the Role of miRNAs in Carcinogenesis Using febit&#8217;s Geniom RT Analyzer</title>
		<link>http://www.bioscreening.net/2008/10/24/the-german-cancer-research-center-investigates-the-role-of-mirnas-in-carcinogenesis-using-febits-geniom-rt-analyzer/</link>
		<comments>http://www.bioscreening.net/2008/10/24/the-german-cancer-research-center-investigates-the-role-of-mirnas-in-carcinogenesis-using-febits-geniom-rt-analyzer/#comments</comments>
		<pubDate>Fri, 24 Oct 2008 18:14:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[RNA Reasearch]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/10/24/the-german-cancer-research-center-investigates-the-role-of-mirnas-in-carcinogenesis-using-febits-geniom-rt-analyzer/</guid>
		<description><![CDATA[LEXINGTON, Mass. (USA), and HEIDELBERG, Germany, Oct. 20, 2008 &#8211; The German Cancer Research Center, also known as DKFZ, in Heidelberg (Germany) chose febitÂ´s newly introduced GeniomÂ® RT Analyzer to investigate the association of microRNAs (miRNAs) and cancer. miRNAs are small pieces of RNA with a maximum length of 23 nucleotides, which have become an [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/10/24/the-german-cancer-research-center-investigates-the-role-of-mirnas-in-carcinogenesis-using-febits-geniom-rt-analyzer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cell-Based Assays: Innovations in Reagents, Technologies &amp; Screening October 23 &#8211; 24, 2008</title>
		<link>http://www.bioscreening.net/2008/10/22/cell-based-assays-innovations-in-reagents-technologies-screening-october-23-24-2008/</link>
		<comments>http://www.bioscreening.net/2008/10/22/cell-based-assays-innovations-in-reagents-technologies-screening-october-23-24-2008/#comments</comments>
		<pubDate>Wed, 22 Oct 2008 20:56:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[ADMET Studies]]></category>
		<category><![CDATA[Cell-based Assays]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[HT Screening]]></category>
		<category><![CDATA[Medicinal Chemistry]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[USA and Canada]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/10/22/cell-based-assays-innovations-in-reagents-technologies-screening-october-23-24-2008/</guid>
		<description><![CDATA[Cell-based assays provide one of the most valuable tools in drug discovery.Â  They are routinely used in target validation, HTS campaigns, structure activity relationship analyses and ADMET studies. Many factors need to be considered in designing, developing and running relevant cell based assays to progress discovery programs.Â  Significant advances continue to be made in assay [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/10/22/cell-based-assays-innovations-in-reagents-technologies-screening-october-23-24-2008/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bio Partners with Illumina to Provide Next Generation Sequencing Analysis Technology</title>
		<link>http://www.bioscreening.net/2008/10/02/clc-bio-partners-with-illumina-to-provide-next-generation-sequencing-analysis-technology/</link>
		<comments>http://www.bioscreening.net/2008/10/02/clc-bio-partners-with-illumina-to-provide-next-generation-sequencing-analysis-technology/#comments</comments>
		<pubDate>Thu, 02 Oct 2008 22:01:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/10/02/clc-bio-partners-with-illumina-to-provide-next-generation-sequencing-analysis-technology/</guid>
		<description><![CDATA[Aarhus, Denmark &#8212; October 2, 2008 &#8212; Following an overwhelming reception of CLC Genomics Workbench 1.0, CLC bio is happy to announce the release of its next major version of their flagship product: CLC Genomics Workbench 2.0. Additionally, CLC bio has taken another important step in leading next generation sequencing data analysis byÂ  becoming an [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/10/02/clc-bio-partners-with-illumina-to-provide-next-generation-sequencing-analysis-technology/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First of 100 Arab Human Genomes Sequenced by Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio</title>
		<link>http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/</link>
		<comments>http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/#comments</comments>
		<pubDate>Tue, 09 Sep 2008 19:06:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/</guid>
		<description><![CDATA[Riyadh, Kingdom of Saudi Arabia &#8212; September 9, 2008 &#8212; An international consortium consisting of Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio have in a joint effort performed an initial sequencing and analysis of the first Arab human genome, as part of a large project to sequence 100 Arab human genomes to map [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/09/09/first-of-100-arab-human-genomes-sequenced-by-saudi-biosciences-beijing-genomics-institute-shenzhen-and-clc-bio/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bio release white paper on the world&#8217;s fastest Next Generation Sequencing assembly algorithm</title>
		<link>http://www.bioscreening.net/2008/07/28/clc-bio-release-white-paper-on-the-worlds-fastest-next-generation-sequencing-assembly-algorithm/</link>
		<comments>http://www.bioscreening.net/2008/07/28/clc-bio-release-white-paper-on-the-worlds-fastest-next-generation-sequencing-assembly-algorithm/#comments</comments>
		<pubDate>Mon, 28 Jul 2008 23:03:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Discoveries, Innovations and Patents]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/28/clc-bio-release-white-paper-on-the-worlds-fastest-next-generation-sequencing-assembly-algorithm/</guid>
		<description><![CDATA[Aarhus Denmark &#8212; July 23, 2008 &#8212; CLC bio has just released a scientific white paper which confirms, that, in benchmarking tests, CLC bioâ€™s new algorithm for assembly of Next Generation Sequencing data is the fastest one available. Not only is CLC bioâ€™s algorithm considerably faster, but it also provides a better quality of the [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/28/clc-bio-release-white-paper-on-the-worlds-fastest-next-generation-sequencing-assembly-algorithm/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AgriGenomics World Congress 2008 29-30 September 2008, Amsterdam, The Netherlands</title>
		<link>http://www.bioscreening.net/2008/07/28/agrigenomics-world-congress-2008-29-30-september-2008-amsterdam-the-netherlands/</link>
		<comments>http://www.bioscreening.net/2008/07/28/agrigenomics-world-congress-2008-29-30-september-2008-amsterdam-the-netherlands/#comments</comments>
		<pubDate>Mon, 28 Jul 2008 21:57:39 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Agriculture Research]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/28/agrigenomics-world-congress-2008-29-30-september-2008-amsterdam-the-netherlands/</guid>
		<description><![CDATA[Select Biosciences is proud to announce their inaugural AgriGenomics World Congress. This year&#8217;s event will take place at the NH Grand Hotel Krasnapolsky in Amsterdam. AgriGenomics.eu Alongside an exhibition of selected scientific posters and service providers, Select Biosciences is organizing a two day event gathering some of the most influential players in the field from [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/28/agrigenomics-world-congress-2008-29-30-september-2008-amsterdam-the-netherlands/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC Genomics Workbench &#8211; CLC bio releases Next Generation Sequencing data analysis solution</title>
		<link>http://www.bioscreening.net/2008/07/18/clc-genomics-workbench-clc-bio-releases-next-generation-sequencing-data-analysis-solution/</link>
		<comments>http://www.bioscreening.net/2008/07/18/clc-genomics-workbench-clc-bio-releases-next-generation-sequencing-data-analysis-solution/#comments</comments>
		<pubDate>Fri, 18 Jul 2008 23:00:45 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[New Products]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/18/clc-genomics-workbench-clc-bio-releases-next-generation-sequencing-data-analysis-solution/</guid>
		<description><![CDATA[Aarhus, Denmark &#8212; June 12, 2008 &#8212; Today, CLC bio released their new Next Generation Sequencing (NGS) solution, CLC Genomics Workbench, which incorporates cutting-edge technology and algorithms, while also supporting and integrating with the rest of a typical NGS workflow. CLC Genomics Workbench is the first comprehensive analysis package which can analyze and visualize data [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/18/clc-genomics-workbench-clc-bio-releases-next-generation-sequencing-data-analysis-solution/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beijing Genomics Institute signs global site license with CLC bio for Next Generation Sequencing software platform</title>
		<link>http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/</link>
		<comments>http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/#comments</comments>
		<pubDate>Fri, 18 Jul 2008 21:34:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[ChemInformatics]]></category>
		<category><![CDATA[Collaborations]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/</guid>
		<description><![CDATA[Aarhus Denmark, July 3rd, 2008 â€“ Beijing Genomics Institute (BGI) has signed a global site license agreement for CLC bio&#8217;s Next Generation Sequencing solution, CLC Genomics Workbench. The site license covers all researchers at all BGI sites, both inside and outside of China. Head of Bioinformatics Division at BGI, Ruiqiang Li states, â€œWe have chosen [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/07/18/beijing-genomics-institute-signs-global-site-license-with-clc-bio-for-next-generation-sequencing-software-platform/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>World Premiere of Next Generation Sequencing solution from CLC bio</title>
		<link>http://www.bioscreening.net/2008/04/25/world-premiere-of-next-generation-sequencing-solution-from-clc-bio/</link>
		<comments>http://www.bioscreening.net/2008/04/25/world-premiere-of-next-generation-sequencing-solution-from-clc-bio/#comments</comments>
		<pubDate>Fri, 25 Apr 2008 21:02:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/04/25/world-premiere-of-next-generation-sequencing-solution-from-clc-bio/</guid>
		<description><![CDATA[Boston, USA &#8212; April 25, 2008 &#8212; On Monday, April 28, CLC bio will officially unveil their new Next Generation Sequencing solution, CLC Genomics Workbench, the first comprehensive analysis package which can analyze and visualize data from all the major Next Generation Sequencing (NGS) platforms, such as SOLiD from Applied Biosystems, 454 GS flx from [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/04/25/world-premiere-of-next-generation-sequencing-solution-from-clc-bio/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CLC bio and University of Copenhagen Sign Site License Agreement</title>
		<link>http://www.bioscreening.net/2008/03/11/clc-bio-and-university-of-copenhagen-sign-site-license-agreement/</link>
		<comments>http://www.bioscreening.net/2008/03/11/clc-bio-and-university-of-copenhagen-sign-site-license-agreement/#comments</comments>
		<pubDate>Tue, 11 Mar 2008 21:05:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioInformatics]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/03/11/clc-bio-and-university-of-copenhagen-sign-site-license-agreement/</guid>
		<description><![CDATA[Copenhagen &#038; Aarhus Denmark, March 11, 2007 &#8212; CLC bio and Department of Biology, Faculty of Science at University of Copenhagen, have signed a site license agreement for CLC bio&#8217;s premier bioinformatics software solution, CLC Combined Workbench, in combination with CLC bio&#8217;s Educational Suite. The deal runs for five years and is for several hundred [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/03/11/clc-bio-and-university-of-copenhagen-sign-site-license-agreement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Seaside Therapeutics Awards $4.5 Million Collaborative Research Contract to Vanderbilt University Medical Center</title>
		<link>http://www.bioscreening.net/2008/02/04/seaside-therapeutics-awards-45-million-collaborative-research-contract-to-vanderbilt-university-medical-center/</link>
		<comments>http://www.bioscreening.net/2008/02/04/seaside-therapeutics-awards-45-million-collaborative-research-contract-to-vanderbilt-university-medical-center/#comments</comments>
		<pubDate>Mon, 04 Feb 2008 20:13:24 +0000</pubDate>
		<dc:creator>Fred</dc:creator>
				<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Drug Development]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2008/02/04/seaside-therapeutics-awards-45-million-collaborative-research-contract-to-vanderbilt-university-medical-center/</guid>
		<description><![CDATA[Seaside Therapeutics announced today the award of a $4.5 million collaborative research contract to Vanderbilt University Medical Center to discover novel compounds to potentially suppress the manifestations of fragile X syndrome. Fragile X syndrome is the most common inherited disorder of brain development and the most common known genetic cause of autism. Individuals with fragile [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2008/02/04/seaside-therapeutics-awards-45-million-collaborative-research-contract-to-vanderbilt-university-medical-center/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ERA-NET PathoGenoMics recognises outstanding PhD theses</title>
		<link>http://www.bioscreening.net/2007/10/25/era-net-pathogenomics-recognises-outstanding-phd-theses/</link>
		<comments>http://www.bioscreening.net/2007/10/25/era-net-pathogenomics-recognises-outstanding-phd-theses/#comments</comments>
		<pubDate>Thu, 25 Oct 2007 16:29:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Education]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Grants and Awards]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/25/era-net-pathogenomics-recognises-outstanding-phd-theses/</guid>
		<description><![CDATA[Increasingly, disease-causing microorganisms are being analysed on a genetic level in the hope of identifying critical factors that might be therapeutically applicable. European research in this area is being promoted under the roof of the ERA-NET PathoGenoMics network. During the 3rd European Conference on Procaryotic Genomics, held from 7 to 10 October in GÃ¶ttingen, Germany, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/25/era-net-pathogenomics-recognises-outstanding-phd-theses/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog</title>
		<link>http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/</link>
		<comments>http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/#comments</comments>
		<pubDate>Thu, 18 Oct 2007 17:11:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[Reagents]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/</guid>
		<description><![CDATA[NEWARK, Del., Oct. 2 /PRNewswire-FirstCall/ &#8212; Strategic Diagnostics Inc. &#8212; today announced the launch of a new internet based catalog of antibody reagents in support of oncology-based research and discovery. These high-quality reagents have all been manufactured utilizing SDI&#8217;s proprietary Genomic Antibody Technology(TM) and will carry the SEQer(TM) brand. The catalog is available at http://antibodies.sdix.com [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/10/18/strategic-diagnostics-launches-initial-oncology-targeted-antibody-reagent-catalog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>European research agenda for pathogenomics adopted</title>
		<link>http://www.bioscreening.net/2007/05/31/european-research-agenda-for-pathogenomics-adopted/</link>
		<comments>http://www.bioscreening.net/2007/05/31/european-research-agenda-for-pathogenomics-adopted/#comments</comments>
		<pubDate>Thu, 31 May 2007 20:50:47 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[PathoGenomics]]></category>
		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Research Projects]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/05/31/european-research-agenda-for-pathogenomics-adopted/</guid>
		<description><![CDATA[Network of Excellence EuroPathoGenomics has undergone its first review Researchers have long been fascinated by microorganisms, as they can be both useful inhabitants of the body and dangerous pathogens. In 2005, to better understand this dual role, 37 researcher teams from 13 different European countries founded the Network of Excellence EuroPathoGenomics (NoE EPG). The members [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/05/31/european-research-agenda-for-pathogenomics-adopted/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BioServe Names Kevin Krenitsky as Chief Executive Officer</title>
		<link>http://www.bioscreening.net/2007/05/31/bioserve-names-kevin-krenitsky-as-chief-executive-officer/</link>
		<comments>http://www.bioscreening.net/2007/05/31/bioserve-names-kevin-krenitsky-as-chief-executive-officer/#comments</comments>
		<pubDate>Thu, 31 May 2007 19:17:55 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/05/31/bioserve-names-kevin-krenitsky-as-chief-executive-officer/</guid>
		<description><![CDATA[Beltsville, MD, May 7, 2007 â€“ BioServe today strengthened its senior management team with the appointment of Kevin Krenitsky, M.D. as Chief Executive Officer.Â  Krenitsky is a highly respected 15-year veteran of the life sciences industry, bringing a wealth of experience in building and managing global biotechnology operations. â€œKevinâ€™s impressive range of experience in diagnostics, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/05/31/bioserve-names-kevin-krenitsky-as-chief-executive-officer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BioServe Acquires Genomics Collaborative</title>
		<link>http://www.bioscreening.net/2007/05/04/bioserve-acquires-genomics-collaborative/</link>
		<comments>http://www.bioscreening.net/2007/05/04/bioserve-acquires-genomics-collaborative/#comments</comments>
		<pubDate>Fri, 04 May 2007 23:20:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Business and Investment]]></category>
		<category><![CDATA[Genomics & Pharmacogenomics]]></category>
		<category><![CDATA[Mergers and Acquisitions]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Press Releases]]></category>

		<guid isPermaLink="false">http://www.bioscreening.net/2007/05/04/bioserve-acquires-genomics-collaborative/</guid>
		<description><![CDATA[BioServe Extends Genomics Services Platform with Premier Industrial Biobank for Biomarker Discovery and Validation Beltsville, MD, May 1st, 2007 â€“ BioServe, a leading provider of genomics services, today announced that it has acquired Genomics Collaborative from SeraCare Life Sciences, Inc. Genomics Collaborative is a leader in facilitating biomarker discovery and validation through its Global RepositoryÂ®, [...]]]></description>
		<wfw:commentRss>http://www.bioscreening.net/2007/05/04/bioserve-acquires-genomics-collaborative/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

